Danielle Nguyen Headshot

Danielle Nguyen

Academic Office Information

danielle.nguyen@utah.edu

Research Interests

  • Economic modeling
  • Health Equity
  • Health Policy
  • Drug pricing and access

Danielle obtained her pharmacy doctorate at Roseman University of Health Sciences and subsequently completed a two-year Health Systems Pharmacy Administration residency at Intermountain Healthcare. After finishing her residency, she continued to expand her clinical and operational skills by continuing to work as a float pharmacist at Intermountain and clinical reviews pharmacist at MRIoA while completing her bachelor’s degree in economics at the University of Utah and working on her master’s degree at Oxford.

As a student, she has completed internships at the congressional district office and medication assistance program. As a float pharmacist, she has worked in internal medicine, critical care, cardiology, neonatal intensive care, and more; she has also covered a pharmacy director’s maternity leave at Park City Hospital during the beginning of the COVID-19 pandemic. Her hope with completing her PhD in Health Outcomes Research is to be able to integrate her clinical, economic, administrative, and managed care knowledge to improve medication access and outcomes in the United States.

Education History

Pharm D Roseman University of Health Science
PharmD 		PharmD
Other Training University of Utah
Economics B.S. with a minor in Political Science 		Economics BS with a minor in Political Science

Selected Publications

Journal Article

  1. Quynh P, Nguyen P, Nguyen H, Phung T, Nguyen D, Duong, K. PARP inhibitors in newly diagnosed or recurrent ovarian cancer maintenance therapy: evidence of efficacy and safety from randomized controlled trials. Biomedical Research and Therapy. 2023 Dec. 10(12), 6090-6102. https://doi.org/10.15419/bmrat.v10i12.851

  2. Panchal R, Nguyen D, Ghule P, Li N, Giannouchos T, Pan RJ, Biskupiak J, Britton L, Nohavec R, Slager S, Ngorsuraches S, Brixner D. Understanding patient cost-sharing thresholds for diabetes treatment attributes via a discrete choice experiment. J Manag Care Spec Pharm. 2023 Feb;29(2):139-150. doi: 10.18553/jmcp.2023.29.2.139. PMID: 36705280.

  3. Ilham S, Willis C, Kim K, Chung KC, Wood BM, Tan MS, Tan CJ, Nguyen D, Brixner DI, Stenehjem DD. Cancer incidence in immunocompromised patients: a single-center cohort study. BMC Cancer. 2023 Jan 9;23(1):33. doi: 10.1186/s12885-022-10497-4. PMID: 36624408.